Rijvers, L., Langelaar, J. v., Bogers, L., Melief, M., Koetzier, S. C., Blok, K. M., . . . Luijn, M. M. v. (2022). Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinib. American Society for Clinical investigation.
Chicago Style (17th ed.) CitationRijvers, Liza, et al. Human T-bet+ B Cell Development Is Associated with BTK Activity and Suppressed by Evobrutinib. American Society for Clinical investigation, 2022.
MLA (9th ed.) CitationRijvers, Liza, et al. Human T-bet+ B Cell Development Is Associated with BTK Activity and Suppressed by Evobrutinib. American Society for Clinical investigation, 2022.
Warning: These citations may not always be 100% accurate.